Stryker Says Not in Talks to Buy Boston Scientific

Shares of Stryker Corp. (SYK)  shot up in premarket trading on Wednesday, June 13, after the medical technology firm said in an 8-K filing that it wasn't in talks to acquire Boston Scientific Corp. (BSX) .

Stryker's shares jumped nearly 7% to $173.89. Shares of Boston Scientific fell 6.5% to $31.65.

The filing came on the heels of a Wall Street Journal article on Monday stating that Kalamazoo, Mich.-based Stryker had recently made a takeover approach to Marlborough Mass.-based Boston Scientific.

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists